Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Miyuki Nishie"'
Autor:
Momoko Kurihara, Katsunori Masaki, Emiko Matsuyama, Masato Fujioka, Reina Hayashi, Saki Tomiyasu, Kotaro Sasahara, Keeya Sunata, Masato Asaoka, Yuto Akiyama, Miyuki Nishie, Misato Irie, Takae Tanosaki, Hiroki Kabata, Koichi Fukunaga
Publikováno v:
Biomolecules, Vol 12, Iss 12, p 1743 (2022)
Reports of eosinophilic pneumonia (EP) as a side effect of dupilumab administration are limited in previous studies. Herein, we report two cases in which EP developed subsequent to the administration of dupilumab for eosinophilic chronic rhinosinusit
Externí odkaz:
https://doaj.org/article/6de0373a93ac457195f3c0b21f6e0279
Autor:
Shunya Takano, Tomoyuki Shimono, Katsunori Masaki, Koichi Fukunaga, Hiroki Kabata, Miyuki Nishie, Taiko Ezaki, Hideo Nakada, Jun Hakamata, Atsushi Hasegawa
Publikováno v:
IEEE/ASME Transactions on Mechatronics. 27:2204-2211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55782968c953fb43ce8de234d349cd06
https://doi.org/10.1109/tmech.2022.3175851
https://doi.org/10.1109/tmech.2022.3175851
Autor:
Takuya Ozawa, Hideki Terai, Akiyoshi Kajino, Shiro Otake, Ayaka Saito, Miyuki Nishie, Yoshikazu Kishino, Hirofumi Kamata, Kentaro Hayashida, Makoto Ishii, Koichi Fukunaga
Publikováno v:
The American journal of case reports. 23
BACKGROUND Diffuse alveolar hemorrhage (DAH) caused by direct oral anticoagulants (DOACs) has increased in recent years with the increase in prescriptions of DOACs. Generally, DOACs are considered to have a lower bleeding risk than the traditional an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e32f2382d9193a1be2256fb5fde67122
https://pubmed.ncbi.nlm.nih.gov/36345226
https://pubmed.ncbi.nlm.nih.gov/36345226
Publikováno v:
BMJ Case Rep
A 31-year-old female physician was diagnosed with bilateral pneumothorax a day after her acupuncture treatment. Her body mass index was 16.9 and she did not have a prior history of respiratory disease or smoking. Acupuncture needles may easily reach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39b784d13c54608008ca47356be4dc9
https://europepmc.org/articles/PMC7929814/
https://europepmc.org/articles/PMC7929814/
Autor:
Michinori Aoe, Hiromi Nakashima, Hisakazu Nishimori, Eisei Kondo, Ken-ichi Matsuoka, Yusuke Mimura, Nobuharu Fujii, Yuka Mimura-Kimura, Takeru Asano, Miyuki Nishie, Yoshinobu Maeda, Mitsune Tanimoto, Keisuke Aoe, Hideaki Fujiwara
Publikováno v:
Transfusion. 56:231-236
BACKGROUND Donor lymphocyte infusion (DLI) is used for treatment of hematologic malignancy relapse or mixed chimerism after allogeneic hematopoietic stem cell transplantation. Although graft-versus-host disease is well recognized as one of the advers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e758fd4544e0cbfa8eb163708588406
https://doi.org/10.1111/trf.13283
https://doi.org/10.1111/trf.13283
Autor:
Miyuki, Nishie, Nobuharu, Fujii, Yusuke, Mimura, Takeru, Asano, Yuka, Mimura-Kimura, Keisuke, Aoe, Michinori, Aoe, Hiromi, Nakashima, Hideaki, Fujiwara, Hisakazu, Nishimori, Ken-Ichi, Matsuoka, Eisei, Kondo, Yoshinobu, Maeda, Mitsune, Tanimoto
Publikováno v:
Transfusion
BACKGROUND Donor lymphocyte infusion (DLI) is used for treatment of hematologic malignancy relapse or mixed chimerism after allogeneic hematopoietic stem cell transplantation. Although graft‐versus‐host disease is well recognized as one of the ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc6556751a3dab1fa13b3822782b2cd3
https://pubmed.ncbi.nlm.nih.gov/26449992
https://pubmed.ncbi.nlm.nih.gov/26449992
Publikováno v:
BMJ Case Reports; 3/1/2021, Vol. 14, p1-3, 3p
Autor:
Koichiro, Kobayashi, Yoshinobu, Maeda, Yoshitaka, Hara, Miyuki, Nishie-Kataoka, Hisakazu, Nishimori, Haruko, Sugiyama, Noriko, Namba, Shiro, Kubonishi, Masami, Niiya, Katsuji, Shinagawa, Kazuma, Ikeda, Mitsune, Tanimoto
Publikováno v:
Anticancer research. 29(5)
Umbilical cord blood transplantation (CBT) has increasingly been used as a therapeutic option for adult patients for whom allogeneic stem-cell transplantation is not indicated, due to the availability of cord blood. However, myeloablative conditionin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e8455f432081670f76a61e5feedf3c4
https://pubmed.ncbi.nlm.nih.gov/19443401
https://pubmed.ncbi.nlm.nih.gov/19443401
Autor:
Mitsune Tanimoto, Miyuki Nishie-Kataoka, Yoshinobu Maeda, Haruko Sugiyama, Takanori Teshima, Koichiro Kobayashi, Hisakazu Nishimori
Publikováno v:
Blood. 112:2331-2331
Chronic graft-versus-host disease (GVHD) is the most common complication in the late stage after allogenic hematopoietic-stem-cell-transplantation (SCT), but the pathophysiology and treatment strategy of chronic GVHD remain poorly defined. Prolonged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a8190560a5ad014887f6320801a3ef5
https://doi.org/10.1182/blood.v112.11.2331.2331
https://doi.org/10.1182/blood.v112.11.2331.2331